Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 45Neoplasm Metastasis 5Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Prostatic Neoplasms, Castration-Resistant 2Ovarian Neoplasms 2Metastatic Castration-Resistant Prostate Cancer 2Melanoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Bulbo-Spinal Atrophy, X-Linked 2Bites and Stings 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Salivary Gland Neoplasms 1Prostate Cancer Metastatic Disease 1Prostate Adenocarcinoma 1Primary Myelofibrosis 1Pancreatic Neoplasms 1PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1Newly Diagnosed Oligometastatic Prostate Cancer 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metastatic Hormone-sensitive Prostate Cancer 1Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1

Interventions

Blood Specimen Collection 5pembrolizumab 2fluciclovine F-18 2Surveys and Questionnaires 2Preoperative Exercise 2Magnetic Resonance Imaging 2Exercise 2Cryosurgery 2Bevacizumab 2tislelizumab 1neratinib 1imetelstat 1daratumumab 1atezolizumab 1abiraterone 1Waiting Lists 1Videotape Recording 1Urine Specimen Collection 1Transcutaneous Electric Nerve Stimulation 1Tomography, X-Ray Computed 1Thoracic Surgical Procedures 1TIC10 compound 1Sulfonylurea Compounds 1Standard of Care 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Serologic Tests 1Sequence Analysis, RNA 1S-Adenosylmethionine 1Referral and Consultation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × abiraterone × 1 year × Clear all
NCT07299292 2025-12-23

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

SMED Clinical Research

Phase 2 Recruiting
60 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡